LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

$75.54
+1.50 (+2.03%)
As of Jun 24, 9:58 PM ET ·
Financial Highlights (FY 2026)
Revenue
163.60M
Net Income
-71,222,514
Gross Margin
91.6%
Profit Margin
-43.5%
Rev Growth
+115.0%
D/E Ratio
1.49
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 91.6% 58.0% 52.5% 52.5%
Operating Margin -32.4% -807.4% 26.8% 26.1%
Profit Margin -43.5% -885.1% 19.2% 19.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 163.60M 12.24M 783.80M 707.55M
Gross Profit 149.92M 7.10M 411.26M 371.25M
Operating Income -53,088,531 -98,848,235 210.20M 184.67M
Net Income -71,222,514 -102,665,771 150.56M 137.41M
Gross Margin 91.6% 58.0% 52.5% 52.5%
Operating Margin -32.4% -807.4% 26.8% 26.1%
Profit Margin -43.5% -885.1% 19.2% 19.4%
Rev Growth +115.0% +2.9% +0.6% +0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.89B 913.17M 962.93M 1.24B
Total Equity 1.27B 611.43M 1.27B 1.28B
D/E Ratio 1.49 1.49 0.76 0.97
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -53,063,396 -104,281,125 266.89M 249.48M
Free Cash Flow 76.52M 82.10M